Literature DB >> 30236224

In Reply.

Christian Karl Spies.   

Abstract

Mesh：

Year:  2018        PMID： 30236224      PMCID： PMC6206254          DOI： 10.3238/arztebl.2018.0596c

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

1.  Five- to 18-year follow-up for treatment of trapeziometacarpal osteoarthritis: a prospective comparison of excision, tendon interposition, and ligament reconstruction and tendon interposition.

Authors:  Soham Gangopadhyay; Helen McKenna; Frank D Burke; Tim R C Davis
Journal:  J Hand Surg Am       Date:  2012-02-03       Impact factor: 2.230

Review 2.  Anatomy and pathomechanics of the thumb.

Authors:  Fraser J Leversedge
Journal:  Hand Clin       Date:  2008-08       Impact factor: 1.907

3.  The field size matters: low dose external beam radiotherapy for thumb carpometacarpal osteoarthritis : Importance of field size.

Authors:  Alexander Kaltenborn; Elke Bulling; Mirko Nitsche; Ulrich Martin Carl; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2016-06-14       Impact factor: 3.621

Review 4.  The Treatment of Primary Arthritis of the Finger and Thumb Joint.

Authors:  Christian Karl Spies; Martin Langer; Peter Hahn; Lars Peter Müller; Frank Unglaub
Journal:  Dtsch Arztebl Int       Date:  2018-04-20       Impact factor: 5.594

5.  The Effect of a Bone Tunnel During Ligament Reconstruction for Trapeziometacarpal Osteoarthritis: A 5-Year Follow-up.

Authors:  Kim R Spekreijse; Guus M Vermeulen; Muhammed A Kedilioglu; Harm P Slijper; Reinier Feitz; Steven E Hovius; Ruud W Selles
Journal:  J Hand Surg Am       Date:  2015-09-09       Impact factor: 2.230
  5 in total
  1 in total

1.  Re-irradiation for humeral epicondylitis : Retrospective analysis of 99 elbows.

Authors:  Matthias G Hautmann; Lukas P Beyer; Matthias Hipp; Ulrich Neumaier; Felix Steger; Barbara Dietl; Katja Evert; Oliver Kölbl; Christoph Süß
Journal:  Strahlenther Onkol       Date:  2019-07-15       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.